| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Escherichia coli (ESBL CIA TEM-7 + CAMHB + pH 5.8) |
- |
- |
0.015 － ? |
Finafloxacin  |
1045 |
| Escherichia coli (ESBL CIA TEM-7 + CAMHB + pH 5.8) |
- |
- |
4 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1045 |
| Escherichia coli (ESBL CIA TEM-7 + CAMHB + pH 7.2) |
- |
- |
0.06 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1045 |
| Escherichia coli (ESBL CIA TEM-7 + CAMHB + pH 7.2) |
- |
- |
0.5 － ? |
Finafloxacin |
1045 |
| Escherichia coli (ESBL) |
0.015 |
0.015 |
≤0.007 － 0.015 |
Meropenem (Merrem) |
1394 |
| Escherichia coli (ESBL) |
0.03 |
0.125 |
<0.008 － 0.5 |
Ertapenem (Invanz) |
4 |
| Escherichia coli (ESBL) |
0.03 |
0.25 |
0.008 － 8 |
Ertapenem (Invanz) |
55 |
| Escherichia coli (ESBL) |
0.06 |
0.12 |
<0.06 － 0.12 |
Meropenem (Merrem) |
6 |
| Escherichia coli (ESBL) |
>0.06 |
>4 |
≤0.03 － >4 |
Gatifloxacin (Tequin) |
412 |
| Escherichia coli (ESBL) |
0.12 |
0.5 |
<0.006 － 0.5 |
Imipenem |
6 |
| Escherichia coli (ESBL) |
0.12 |
0.5 |
0.06 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
6 |
| Escherichia coli (ESBL) |
0.12 |
0.5 |
≤0.12 － 4 |
Imipenem |
371 |
| Escherichia coli (ESBL) |
0.12 |
0.5 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
444 |
| Escherichia coli (ESBL) |
0.125 |
0.25 |
0.03 － 2 |
Imipenem |
4 |
| Escherichia coli (ESBL) |
0.25 |
0.25 |
0.12 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
42 |
| Escherichia coli (ESBL) |
0.25 |
0.25 |
0.25 － 4 |
Meropenem (Merrem) |
55 |
| Escherichia coli (ESBL) |
0.25 |
0.5 |
? － ? |
Imipenem |
36 |
| Escherichia coli (ESBL) |
0.25 |
0.5 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
36 |
| Escherichia coli (ESBL) |
0.25 |
1 |
0.25 － 1 |
Imipenem |
42 |
| Escherichia coli (ESBL) |
0.25 |
1 |
0.25 － 2 |
Tigecycline (GAR-936, Tigacyl) |
55 |
| Escherichia coli (ESBL) |
>0.25 |
>2 |
≤0.25 － >2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
412 |
| Escherichia coli (ESBL) |
>0.25 |
>2 |
<0.25 － >2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
6 |
| Escherichia coli (ESBL) |
0.25 |
4 |
≤0.12 － >16 |
Cefepime (Maxipime) |
412 |
| Escherichia coli (ESBL) |
0.25 |
8 |
0.25 － >64 |
Levofloxacin (Levaquin, Quixin) |
55 |
| Escherichia coli (ESBL) |
0.5 |
0.5 |
0.5 － 0.5 |
Cefminox |
1394 |
| Escherichia coli (ESBL) |
0.5 |
0.5 |
0.5 － 1 |
Imipenem |
55 |
| Escherichia coli (ESBL) |
≤0.5 |
≤0.5 |
≤0.5 － 4 |
Imipenem |
412 |
| Escherichia coli (ESBL) |
0.5 |
0.5 |
0.5 － 16 |
Cefepime (Maxipime) |
55 |